EX-32.2 5 f10q1223ex32-2_inmed.htm CERTIFICATION

Exhibit 32.2


Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002


Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Jonathan Tegge, the Chief Financial Officer of InMed Pharmaceuticals Inc. (the “Company”), hereby certify that, to my knowledge:


  1. The Quarterly Report on Form 10-Q for the quarter ended December 31, 2023 (the “Report”) of the Company fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and


  2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: February 13, 2024


  /s/ Jonathan Tegge
  Name: Jonathan Tegge
  Title: Interim Chief Financial Officer